Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date28 Dec 2018 |
100 Clinical Results associated with Guangzhou Qiji Medicine Technology Co.,Ltd.
0 Patents (Medical) associated with Guangzhou Qiji Medicine Technology Co.,Ltd.
100 Deals associated with Guangzhou Qiji Medicine Technology Co.,Ltd.
100 Translational Medicine associated with Guangzhou Qiji Medicine Technology Co.,Ltd.